Name: Ethylmethylthiambutene
Type: Opioid
AKA: N/A
|
II. Natural Derivative
Synthetic substance, no natural derivative
|
III. Chemical Profile (IUPAC name)
|
IV. History
Ethylmethylthiambutene, a synthetic compound, was developed for research purposes. It is studied for its effects on the central nervous system and its potential applications in medicine.
|
V. Legal Information
Ethylmethylthiambutene, an opioid analgesic, is classified as a Schedule I controlled substance in the US, making it illegal. Many countries have similarly banned it due to its high potential for abuse and lack of accepted medical use. The UNODC monitors synthetic opioids, emphasizing the need for strict controls to prevent misuse and address the opioid crisis.
US Federal Schedule - I
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
VI. Physical Effects
Ethylmethylthiambutene is a synthetic opioid with potent analgesic effects. It acts as a downer, causing sedation and respiratory depression. Short-term use is effective for pain management, but long-term use can lead to addiction, tolerance, and severe health issues. Overdose risks include fatal respiratory depression. Safe use requires strict dosing and medical supervision. Recent research explores its efficacy and risks compared to other opioids. |
VII. Psychological Effects
Ethylmethylthiambutene is a synthetic opioid producing euphoria, sedation, and pain relief. Immediate effects include mood elevation and cognitive impairment. Long-term use can lead to addiction, tolerance, and severe withdrawal symptoms. Chronic use is associated with depression, anxiety, and cognitive decline. Recent research emphasizes the high abuse potential and neurotoxicity of opioids.
|
VIII. Culture
Ethylmethylthiambutene is a research chemical with stimulant properties, classifying it as an upper. Short-term use may increase alertness and energy, while long-term effects are not well-documented. Overdose risks are moderate, potentially causing severe agitation and cardiovascular issues. Safe dosages are not well-established, with lower doses advised. Recent research focuses on its psychoactive potential and health risks. Physical effects may include increased heart rate, elevated blood pressure, and potential for severe agitation.
|